What are the characteristic EKG (electrocardiogram) findings in a patient with suspected cardiac amyloidosis, particularly those with a history of multiple myeloma or chronic inflammatory diseases?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

EKG Findings in Cardiac Amyloidosis

The most characteristic EKG finding in cardiac amyloidosis is low QRS voltage in limb leads (≤0.5 mV) despite increased left ventricular wall thickness on echocardiography—this voltage-to-mass discordance occurs in approximately 50% of AL amyloidosis and 25% of ATTR amyloidosis cases. 1, 2, 3

Primary Diagnostic EKG Features

Low Voltage Pattern

  • Low QRS voltage in limb leads (amplitude ≤0.5 mV in each limb lead) is present in 54.5% of patients with cardiac amyloidosis, making it the most common EKG abnormality 3
  • This finding is particularly significant when combined with increased left ventricular wall thickness (≥12 mm) on echocardiography—a discordance that is highly specific for cardiac amyloidosis 4, 1, 2
  • Low voltage occurs in approximately 50% of AL amyloidosis patients and 25% of ATTR amyloidosis patients 1, 2
  • The voltage-to-mass ratio has greater diagnostic accuracy than QRS voltage alone 5

Pseudo-Infarct Pattern

  • Pathological Q waves in at least two contiguous leads without obstructive coronary artery disease occur in 40.2% of cardiac amyloidosis patients 3
  • This pseudo-infarct pattern is significantly more common in cardiac amyloidosis compared to systemic amyloidosis without cardiac involvement (40.2% vs 4.6%, P < 0.001) 3
  • The combination of low voltage on limb leads AND pseudo-infarct pattern has 96% positive predictive value and 98% specificity for cardiac amyloidosis 3

Secondary EKG Abnormalities

Arrhythmias

  • Atrial arrhythmias (primarily atrial fibrillation) occur in 15.9% of cardiac amyloidosis patients compared to 3.4% in systemic amyloidosis without cardiac involvement 3
  • Atrioventricular block is present in 14.8% of cardiac amyloidosis patients versus 1.1% in controls (P = 0.001) 3
  • Conduction system infiltration by amyloid deposits can result in bundle branch blocks 5

Additional Findings

  • Fragmented QRS complexes are significantly associated with the extent of late gadolinium enhancement on cardiac MRI and have independent prognostic value (hazard ratio: 2.034) 6
  • QRS duration and the Sokolow index correlate with amyloid burden as measured by extracellular volume on cardiac MRI 6

Diagnostic Algorithm Using EKG

High Specificity Combination

  • When both low voltage on limb leads AND pseudo-infarct pattern are present together (28% of cardiac amyloidosis cases), the specificity is 98% and positive predictive value is 96% 3
  • This combination should immediately trigger comprehensive workup including monoclonal protein screening, echocardiography, and consideration of cardiac MRI or nuclear imaging 4, 1

Voltage-to-Mass Ratio in Bundle Branch Block

  • In patients with bundle branch block, standard voltage criteria may not apply 5
  • Total QRS score/left ventricular wall thickness ratio with a cutoff of 92.5 mV/cm is 100% sensitive and 83% specific for cardiac amyloidosis in patients with bundle branch block 5
  • This indexed voltage measurement is superior to absolute voltage measurements when conduction abnormalities are present 5

Clinical Context and Pitfalls

Important Caveats

  • Low voltage is NOT universally present—it can range from 20-74% depending on the series and amyloidosis subtype 5
  • The absence of low voltage does NOT exclude cardiac amyloidosis 5
  • In patients with chronic inflammatory diseases or multiple myeloma, the combination of increased wall thickness on echo with low voltage on EKG should raise immediate suspicion for cardiac amyloidosis 4, 7

Prognostic Value

  • Fragmented QRS remains an independent predictor of mortality even after adjusting for clinical variables 6
  • However, EKG characteristics lose independent prognostic value when cardiac MRI parameters (late gadolinium enhancement and extracellular volume) are included in analysis 6
  • The Sokolow index also shows independent prognostic value in AL amyloidosis 6

Integration with Other Diagnostic Modalities

  • EKG should be interpreted alongside echocardiography as the first-line diagnostic approach, with the voltage-to-mass discordance being the key diagnostic clue 4, 1, 2
  • When EKG shows suggestive findings (low voltage, pseudo-infarct pattern, or their combination), proceed immediately with monoclonal protein screening (serum and urine immunofixation electrophoresis, serum free light chains) 4, 1
  • Cardiac MRI is indicated when EKG and echocardiography are suggestive but not definitive, particularly for tissue characterization 4
  • Nuclear imaging with 99mTc-PYP/DPD/HMDP can be diagnostic for ATTR amyloidosis without biopsy when grade 2-3 uptake is present and monoclonal protein screening is negative 4

References

Guideline

Amiloidosis Cardíaca

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management Approach for Low Voltage on ECG

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The findings of electrocardiography in patients with cardiac amyloidosis.

Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc, 2013

Guideline

Cardiac MRI vs Echocardiography for Diagnosing Cardiac Amyloidosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.